Sleep - Wake cycles and cognitive functioning in schizophrenia

British Journal of Psychiatry

Volumn 198, Issue 4, 2011, Pages 269-276

  Bromundt, Vivien ^a   Köster, Matthias ^a   Georgiev Kill, Angela ^a   Opwis, Klaus ^b   Wirz Justice, Anna ^a   Stoppe, Gabriela ^a   Cajochen, Christian ^c  

^a Psychiatric Hospital   (Switzerland)

^b Department of General Psychology and Methodology ^*  (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ACTIMETRY; ADULT; AGE DISTRIBUTION; ARTICLE; ATTENTION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; DAYTIME SOMNOLENCE; EXECUTIVE FUNCTION; FEMALE; FRONTAL LOBE; HORMONE RELEASE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOLOGIC TEST; SALIVA ANALYSIS; SCHIZOPHRENIA; SEMANTICS; SLEEP PARAMETERS; SLEEP WAKING CYCLE; STROOP TEST; TASK PERFORMANCE; VERBAL FLUENCY; VERBALIZATION;

ACTIGRAPHY; ADULT; CIRCADIAN RHYTHM; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SALIVA; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM; STATISTICS AS TOPIC;

EID: 79953678371     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.110.078022     Document Type: Article

References (40)

1. Monti JM, Monti D. Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev 2004; 8: 133-48. (Pubitemid 38445488)
2. Monti JM, Monti D. Sleep disturbance in schizophrenia. Int Rev Psychiatry 2005; 17: 247-53. (Pubitemid 40942997)
3. Cohrs S. Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics. CNS Drugs 2008; 22: 939-62.
4. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 1992; 49: 651-68.
5. Chouinard S, Poulin J, Stip E, Godbout R. Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull 2004; 30: 957-67. (Pubitemid 40469529)
6. Yamashita H, Morinobu S, Yamawaki S, Horiguchi J, Nagao M. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Res 2002; 109: 137-42. (Pubitemid 34258492)
7. Staedt J, Dewes D, Danos P, Stoppe G. Can chronic neuroleptic treatment promote sleep disturbances in elderly schizophrenic patients? Int J Geriatr Psychiatry 2000; 15: 170-6.
8. Wirz-Justice A, Cajochen C, Nussbaum P. A schizophrenic patient with an arrhythmic circadian rest-activity cycle. Psychiatry Res 1997; 73: 83-90. (Pubitemid 28032210)
9. Wirz-Justice A, Haug HJ, Cajochen C. Disturbed circadian rest-activity cycles in schizophrenia patients: an effect of drugs? Schizophr Bull 2001; 27: 497-502.
10. Wulff K, Joyce E, Middleton B, Dijk DJ, Foster RG. The suitability of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: a case report. Chronobiol Int 2006; 23: 485-95. (Pubitemid 43739059)
11. Rao ML, Gross G, Strebel B, Halaris A, Huber G, Bräuning P, et al. Circadian rhythm of tryptohan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol Psychiatry 1994; 35: 151-63. (Pubitemid 24078480)
12. Monteleone P, Maj M, Fusco M, Kemali D, Reiter RJ. Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophr Res 1992; 7: 77-84.
13. Mann K, Rossbach W, Muller MJ, Muller-Siecheneder F, Pott T, Linde I, et al. Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine. Psychoneuroendocrinology 2006; 31: 256-64. (Pubitemid 41740445)
14. Banich MT, Mackiewicz KL, Depue BE, Whitmer AJ, Miller GA, Heller W. Cognitive control mechanisms, emotion and memory: a neural perspective with implications for psychopathology. Neurosci Biobehav Rev 2009; 33: 613-30.
15. Silver H, Feldman P, Bilker W, Gur RC. Working memory deficit as a core neuropsychological dysfunction in schizophrenia. Am J Psychiatry 2003; 160: 1809-16. (Pubitemid 41103315)
16. Maldonado-Aviles JG, Curley AA, Hashimoto T, Morrow AL, Ramsey AJ, O'Donnell P, et al. Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. Am J Psychiatry 2009; 166: 450-9.
17. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-76. (Pubitemid 18039085)
18. Kay SR, Opler LA, Fiszbein A. Structured Clinical Interview for the Positive and Negative Syndrome Scale SCI-PANSS (German trans M Gerhold, M Huss, & M Luecke). Multi-Health Systems, 1999.
19. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799-812.
20. Guy WE. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare, 1976.
21. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212: 11-9.
22. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213. (Pubitemid 19144991)
23. Rey MJ, Schulz P, Costa C, Dick P, Tissot R. Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol 1989; 4: 95-104.
24. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64: 663-7. (Pubitemid 36750143)
25. Nose M, Tansella M, Thornicroft G, Schene A, Becker T, Veronese A, et al. Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages? Int Clin Psychopharmacol 2008; 23: 287-90.
26. Van Someren EJ, Swaab DF, Colenda CC, Cohen W, McCall WV, Rosenquist PB. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int 1999; 16: 505-18. (Pubitemid 29362572)
27. Tonetti L, Pasquini F, Fabbri M, Belluzzi M, Natale V. Comparison of two different actigraphs with polysomnography in healthy young subjects. Chronobiol Int 2008; 25: 145-53. (Pubitemid 351300160)
28. Weber JM, Schwander JC, Unger I, Meier D. A direct ultrasensitive RIA for the determination of melatonin in human saliva: comparison with serum levels. Sleep Res 1997; 26: 757.
29. Reitan RM. Validity of the trail making test as an indication for organic brain damage. Percept Mot Skills 1958; 8: 271-6.
30. Bäumler G. Farbe-Wort-Interferenztest (FWIT) nach J.R. Stroop [in German]. Hogrefe, 1985.
31. Kalbe E, Kessler J, Calabrese P, Smith R, Passmore AP, Brand M, et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004; 19: 136-43. (Pubitemid 38247848)
32. Janno S, Holi MM, Tuisku K, Wahlbeck K. Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population. BMC Neurol 2005; 5: 5.
33. Pugin F, Viola AU, Chellappa SL, Archer S, Dijk DJ, Cajochen C. Can PER3 length polymorphism predict sleep duration in older individuals? Neuropsychobiology 2009; 59: 255.
34. Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999; 14: 167-77. (Pubitemid 29108542)
35. Wright KP Jr, Hull JT, Hughes RJ, Ronda JM, Czeisler CA. Sleep and wakefulness out of phase with internal biological time impairs learning in humans. J Cogn Neurosci 2006; 18: 508-21. (Pubitemid 43763856)
36. Oosterman JM, van Someren EJ, Vogels RL, Van Harten B, Scherder EJ. Fragmentation of the rest-activity rhythm correlates with age-related cognitive deficits. J Sleep Res 2009; 18: 129-35.
37. Bhatia T, Garg K, Pogue-Geile M, Nimgaonkar V, Deshpande S. Executive functions and cognitive deficits in schizophrenia: comparisons between probands, parents and controls in India. J Postgrad Med 2009; 55: 3-7.
38. Harrison Y, Horne JA, Rothwell A. Prefrontal neuropsychological effects of sleep deprivation in young adults - a model for healthy aging? Sleep 2000; 23: 1067-73.
39. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009; 23: 315-36.
40. Sagaspe P, Sanchez-Ortuno M, Charles A, Taillard J, Valtat C, Bioulac B, et al. Effects of sleep deprivation on Color-Word, Emotional, and Specific Stroop interference and on self-reported anxiety. Brain Cogn 2006; 60: 76-87.